Insights from ELCC 2024
ELCC 2024 Summary: "Biomarker Exploration of IO in Early Lung Cancer - Who Will Benefit and What Drives Treatment Resistance"
By
Insights from ELCC 2024
FEATURING
Martin Schuler
By
Insights from ELCC 2024
FEATURING
Martin Schuler
Comments 0
Login to view comments.
Click here to Login
